References
Lughezzani G, et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the International Union Against Cancer-staging system: a North American validation. Eur J Cancer. 46, 713–719, https://doi.org/10.1016/j.ejca.2009.12.007 (2010).
Fassnacht M, et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer. 115, 243–250, https://doi.org/10.1002/cncr.24030 (2009).
Asare EA, et al. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease. Surgery. 156, 1378–1385; discussion 1385–1376, https://doi.org/10.1016/j.surg.2014.08.018 (2014).
Amin MB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 67, 93–99, https://doi.org/10.3322/caac.21388 (2017).
Nilubol N, Patel D, and Kebebew E. Does lymphadenectomy improve survival in patients with adrenocortical carcinoma? A population-based study. World J Surg. 40, 697–705, https://doi.org/10.1007/s00268-015-3283-2 (2016).
Poorman CE, Ethun CG, Postlewait LM, et al. A novel T-stage classification system for adrenocortical carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group. Ann Surg Oncol. 25, 520–527 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have no conflicts of interest to disclose.
Additional information
This ASO Author Reflections is a brief invited commentary on the article “A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group,” Ann Surg Oncol. 2018; 25:520–527.
Rights and permissions
About this article
Cite this article
Poorman, C.E., Ethun, C.G. & Maithel, S.K. ASO Author Reflections: Incorporating Lymphovascular Invasion to Improve the Prognostic Reliability of the T-Staging System for Adrenocortical Carcinoma—A Multicenter Study. Ann Surg Oncol 25 (Suppl 3), 862–863 (2018). https://doi.org/10.1245/s10434-018-6876-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6876-9